-
1
Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics
Published 2021-01-01Get full text
Article -
2
Predicting the Need for Supplemental Oxygen During Airline Flight in Patients with Chronic Pulmonary Disease: A Comparison of Predictive Equations and Altitude Simulation
Published 2009-01-01“…BACKGROUND: Patients with chronic pulmonary diseases are at increased risk of hypoxemia when travelling by air. …”
Get full text
Article -
3
Fungal Infections: Their Diagnosis and Treatment in Transplant Recipients
Published 2012-01-01“…The choice of a prophylactic agent should be based upon its ease of administration, lack of adverse effects, reduced likelihood of potential drug interactions, and its efficacy in patients with established risk factors and comorbid disease processes that include renal, hepatic, and chronic pulmonary disease. The indications for the use of currently available antifungal agents, their adverse effects, drug interactions, ease of dosing, and applicability in patients with preexisting disease states, and especially in liver transplant recipients, are presented in this paper.…”
Get full text
Article -
4
A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal Muscle
Published 2016-01-01“…Although the mechanisms are largely unidentified, the chronic or intermittent hypoxic patterns occurring with respiratory diseases, such as chronic pulmonary disease or obstructive sleep apnea (OSA) and obesity, are commonly associated with glucose intolerance. …”
Get full text
Article -
5
The Immune Response and Its Therapeutic Modulation in Bronchiectasis
Published 2012-01-01“…Bronchiectasis (BC) is a chronic pulmonary disease with tremendous morbidity and significant mortality. …”
Get full text
Article -
6
Risk factor of postoperative pulmonary complications after colorectal cancer surgery: an analysis of nationwide inpatient sample
Published 2025-01-01“…Our study found that age, gender, number of comorbidities, type and location of hospital, and certain preoperative comorbidities, such as fluid and electrolyte disorders (odd ratio [OR] 2.53), coagulopathy (OR 2.16), congestive heart failure (OR 1.91), and chronic pulmonary disease (OR 1.57) were the risk factors of PPCs. …”
Get full text
Article -
7
Impaired Growth during Childhood in Patients with Primary Ciliary Dyskinesia
Published 2013-01-01“…Primary ciliary dyskinesia (PCD) leads to recurrent/chronic respiratory infections, resulting in chronic inflammation and potentially in chronic pulmonary disease with bronchiectasis. We analyzed longitudinal data on body length/height and body mass index (BMI) for 29 children and young adults with PCD aging 1.5–24 years (median, 14.5) who had been diagnosed at the age of 0.5–17 years (median, 8). …”
Get full text
Article -
8
Correlation between the white blood cell/platelet ratio and 28-day all-cause mortality in cardiac arrest patients: a retrospective cohort study based on machine learning
Published 2025-01-01“…Subgroup analyses indicated that elevated WPR was particularly associated with increased mortality in males, elderly patients, married individuals, and those with chronic pulmonary disease.ConclusionWPR serves as an independent and reliable prognostic biomarker for 28-day mortality in cardiac arrest patients. …”
Get full text
Article -
9
Retrospective analysis of the occurrence, potential risk factors and medical significance of pulmonary complications after total shoulder arthroplasty from the National Inpatient S...
Published 2025-01-01“…The ailments at this period that were most likely to result in pulmonary problems were ulcer (adjusted odds ratio [AOR] = 9.43; 95% CI, 4.99–46.91), pulmonary circulation disorders (AOR = 9.01; 95% CI, 4.56– 31.92), weight loss (AOR = 4.84; 95% CI, 2.15–10.88), fluid and electrolyte disorders (AOR = 3.55; 95% CI, 2.55–4.95), alcohol abuse (AOR = 1.56; 95% CI, 1.08–2.26), congestive heart failure (AOR = 3.09; 95% CI, 1.83–5.24), chronic pulmonary disease (AOR = 2.45; 95% CI, 1.60–3.75), deficiency anaemia (AOR = 1.56; 95% CI, 1.08–2.26), depression (AOR = 1.47; 95% CI, 1.03–2.11) and obesity (AOR = 1.46; 95% CI, 1.01–2.11). …”
Get full text
Article -
10
Association between red blood cell distribution width-to-albumin ratio and prognosis in post-cardiac arrest patients: data from the MIMIC-IV database
Published 2025-01-01“…The prognostic value of the RAR index for 180-day mortality was consistent across subgroups, and a significant interaction was observed in patients who were white, those with chronic pulmonary disease, or those without cerebrovascular disease.ConclusionThe RAR index is an independent risk factor for 30- and 180-day all-cause mortality in post-CA patients. …”
Get full text
Article -
11
Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Published 2017-01-01“…These studies thus imply distinct mechanisms of Wnt/β-catenin signaling in the pathogenesis of these two chronic pulmonary diseases, indicating potential targets for COPD and IPF treatments. …”
Get full text
Article -
12
A prediction study on the occurrence risk of heart disease in older hypertensive patients based on machine learning
Published 2025-01-01“…Older hypertensive patients with baseline comorbid dyslipidemia, chronic pulmonary diseases, arthritis or rheumatic diseases faced a higher risk of future heart disease. …”
Get full text
Article -
13
Airway basal stem cell therapy for lung diseases: an emerging regenerative medicine strategy
Published 2025-01-01“…Abstract Chronic pulmonary diseases pose a prominent health threat globally owing to their intricate pathogenesis and lack of effective reversal therapies. …”
Get full text
Article -
14
Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
Published 2019-01-01“…In this review article, we described molecular mechanisms involved in MSC-based therapy of acute and chronic pulmonary diseases and emphasized current knowledge and future perspectives related to the therapeutic application of MSCs in patients suffering from acute respiratory distress syndrome, pneumonia, asthma, chronic obstructive pulmonary diseases, and idiopathic pulmonary fibrosis.…”
Get full text
Article -
15
Asymptomatic lung abscess of aspergillus in a female without previous lung diseases or immunocompromise: a case report
Published 2025-01-01“…Interestingly, this patient had no history of tuberculosis or chronic pulmonary diseases. Other immunocompromised conditions were also denied through history inquest and laboratory tests. …”
Get full text
Article -
16
Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience
Published 2020-01-01“…As a result, incidence of acute and chronic pulmonary diseases is higher. Interestingly, pulmonary morbidity in PID and AATD share similar features. …”
Get full text
Article -
17
Associations of short-term exposure to air pollution with risk of pulmonary space-occupying lesions morbidity based on a time-series study
Published 2025-01-01“…Abstract Background Pulmonary space-occupying lesions are typical chronic pulmonary diseases that contribute significantly to healthcare resource use and impose a large disease burden in China. …”
Get full text
Article -
18
Aspirin-triggered resolvin D1 modulates pulmonary and neurological inflammation in an IL-22 knock-out organic dust exposure mouse model
Published 2024-12-01“…Agriculture dust contains many organic immunogenic compounds, and organic dust exposure is strongly associated with the development of immune-mediated chronic pulmonary diseases such as chronic obstructive pulmonary disease (COPD). …”
Get full text
Article